Phosphorylation of Estrogen Receptor α Blocks Its Acetylation and Regulates Estrogen Sensitivity

Estrogen receptor (ER) α is mutated (lysine 303 to arginine, K303R) in approximately one third of premalignant breast hyperplasias, which renders breast cancer cells expressing the mutant receptor hypersensitive for proliferation in response to low doses of estrogen. It is known that ERα is posttranslationally modified by protein acetylation and phosphorylation by a number of secondary messenger signaling cascades. The K303R ERα mutation resides at a major protein acetylation site adjacent to a potential protein kinase A (PKA) phosphorylation site at residue 305 within the hinge domain of the receptor. Mutation of this phosphorylation site to aspartic acid to mimic constitutive phosphorylation blocks acetylation of the K303 ERα site and generates an enhanced transcriptional response similar to that seen with the naturally occurring K303R mutant receptor. Activation of PKA signaling by the cell-permeable cyclic AMP (cAMP) analog 8-bromo-cAMP further enhances estrogen sensitivity of the mutant receptor, whereas a specific PKA inhibitor antagonizes this increase. We propose that the hypersensitive ERα mutant breast cancer phenotype involves an integration of coupled acetylation and phosphorylation events by upstream signaling molecules.

[1]  R. Carlson,et al.  Sequential Hormonal Therapy for Metastatic Breast Cancer after Adjuvant Tamoxifen or Anastrozole , 2004, Breast Cancer Research and Treatment.

[2]  G. Tritsch,et al.  The stimulation of growth of mammalian cells in vitro by a peptide fraction from enzymatic digests of serum. , 1966, Experimental Cell Research.

[3]  G. Gerton,et al.  A-kinase anchor proteins in endocrine systems and reproduction , 2001, Trends in Endocrinology & Metabolism.

[4]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[5]  R. Lanz,et al.  Nuclear receptor coregulators: cellular and molecular biology. , 1999, Endocrine reviews.

[6]  V. Ogryzko,et al.  p300 and p300/cAMP-response Element-binding Protein-associated Factor Acetylate the Androgen Receptor at Sites Governing Hormone-dependent Transactivation* , 2000, The Journal of Biological Chemistry.

[7]  Simak Ali,et al.  Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α , 2001, The Journal of Biological Chemistry.

[8]  Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation. , 2000, Molecular endocrinology.

[9]  P. Roach,et al.  A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. , 1994, The Journal of biological chemistry.

[10]  J. Hur,et al.  Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. , 2001, Genes & development.

[11]  M. Pike,et al.  Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. , 1993, Epidemiologic reviews.

[12]  P. Driggers,et al.  Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling , 2002, Trends in Endocrinology & Metabolism.

[13]  F. Kashanchi,et al.  Phosphorylation of p53 Serine 15 Increases Interaction with CBP* , 1998, The Journal of Biological Chemistry.

[14]  Rakesh Kumar,et al.  P21‐activated kinase‐1 phosphorylates and transactivates estrogen receptor‐α and promotes hyperplasia in mammary epithelium , 2002, The EMBO journal.

[15]  M. Baum.  The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal (PM) women. , 2001 .

[16]  J. Tobias.  The ATAC ('Arimidex', tamoxifen, alone or in combination) adjuvant breast cancer trial in postmenopausal (PM) women , 2002 .

[17]  M. Conaway,et al.  Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol. , 2002, Endocrinology.

[18]  S. Shenolikar,et al.  Mutations of the serine phosphorylated in the protein phosphatase-1-binding motif in the skeletal muscle glycogen-targeting subunit. , 2000, The Biochemical journal.

[19]  J. Font de Mora,et al.  AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor , 2000, Molecular and Cellular Biology.

[20]  D. Heitjan,et al.  Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. , 1995, The Journal of clinical endocrinology and metabolism.

[21]  Carolyn L. Smith,et al.  Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains. , 2003, Molecular endocrinology.

[22]  R. Evans,et al.  Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.

[23]  P. Chambon,et al.  Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding. , 1989, Molecular endocrinology.

[24]  Mahadev Rao,et al.  The Androgen Receptor Acetylation Site Regulates cAMP and AKT but Not ERK-induced Activity* , 2004, Journal of Biological Chemistry.

[25]  J. Blenis,et al.  pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167 , 1998, Molecular and Cellular Biology.

[26]  A. Floore,et al.  Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer. , 2004, Cancer cell.

[27]  E. Shibuya.  G2 Cell Cycle Arrest: A Direct Link Between PKA and Cdc25C , 2003, Cell cycle.

[28]  N. Weigel,et al.  8-Bromo-Cyclic AMP Induces Phosphorylation of Two Sites in SRC-1 That Facilitate Ligand-Independent Activation of the Chicken Progesterone Receptor and Are Critical for Functional Cooperation between SRC-1 and CREB Binding Protein , 2000, Molecular and Cellular Biology.

[29]  J. Robertson,et al.  Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer. , 1999, Endocrine-related cancer.

[30]  T. Kundu,et al.  p300-mediated Acetylation of Human Transcriptional Coactivator PC4 Is Inhibited by Phosphorylation* , 2001, The Journal of Biological Chemistry.

[31]  S. Fuqua,et al.  Androgen Receptor Acetylation Governs trans Activation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation and trans-Repression Function , 2002, Molecular and Cellular Biology.

[32]  Yumay Chen,et al.  Emerging roles of BRCA1 in transcriptional regulation and DNA repair , 1999, Journal of cellular physiology.

[33]  G. Tortora,et al.  Protein Kinase A as Target for Novel Integrated Strategies of Cancer Therapy , 2002, Annals of the New York Academy of Sciences.

[34]  S. Hilsenbeck,et al.  A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. , 2000, Cancer research.

[35]  M. Dowsett,et al.  Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen Deprivation* , 2003, Journal of Biological Chemistry.

[36]  Chenguang Wang,et al.  Histone acetylation/deacetylation as a regulator of cell cycle gene expression. , 2004, Methods in molecular biology.

[37]  M. Garabedian,et al.  Potentiation of Human Estrogen Receptor α Transcriptional Activation through Phosphorylation of Serines 104 and 106 by the Cyclin A-CDK2 Complex* , 1999, The Journal of Biological Chemistry.

[38]  Angélique Gougelet,et al.  Various Phosphorylation Pathways, Depending on Agonist and Antagonist Binding to Endogenous Estrogen Receptor α (ERα), Differentially Affect ERα Extractability, Proteasome-Mediated Stability, and Transcriptional Activity in Human Breast Cancer Cells , 2003 .

[39]  C. Osborne,et al.  Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. , 2001, Cancer research.

[40]  J. Lamb,et al.  Regulation of the Functional Interaction between Cyclin D1 and the Estrogen Receptor , 2000, Molecular and Cellular Biology.

[41]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[42]  M. Conaway,et al.  Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[43]  E. Kandel,et al.  Enhancement of Memory-Related Long-Term Facilitation by ApAF, a Novel Transcription Factor that Acts Downstream from Both CREB1 and CREB2 , 2000, Cell.

[44]  B. Katzenellenbogen,et al.  Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens. , 1994, Molecular endocrinology.

[45]  L. Bordoli,et al.  Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity. , 2001, Nucleic acids research.

[46]  B. Katzenellenbogen,et al.  Direct Acetylation of the Estrogen Receptor α Hinge Region by p300 Regulates Transactivation and Hormone Sensitivity* , 2001, The Journal of Biological Chemistry.

[47]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[48]  M Karin,et al.  Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. , 2001, Molecular endocrinology.

[49]  K. Sakaguchi,et al.  DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.

[50]  W. Miller.  Regulatory Subunits of PKA and Breast Cancer , 2002, Annals of the New York Academy of Sciences.

[51]  R. Evans,et al.  Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an Acetylase , 1999, Cell.

[52]  Carolyn L. Smith,et al.  Mechanistic Differences in the Activation of Estrogen Receptor-α (ERα)- and ERβ-dependent Gene Expression by cAMP Signaling Pathway(s)* , 2003, The Journal of Biological Chemistry.

[53]  D. Edwards,et al.  The Steroid Receptor Coactivator-1 Contains Multiple Receptor Interacting and Activation Domains That Cooperatively Enhance the Activation Function 1 (AF1) and AF2 Domains of Steroid Receptors* , 1998, The Journal of Biological Chemistry.

[54]  Carolyn L. Smith,et al.  Subnuclear Trafficking of Estrogen Receptor-α and Steroid Receptor Coactivator-1 , 2000 .

[55]  B. Katzenellenbogen,et al.  Estrogen receptor activation function 1 works by binding p160 coactivator proteins. , 1998, Molecular endocrinology.

[56]  B. Katzenellenbogen,et al.  Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. , 1993, Molecular endocrinology.

[57]  I. Ellis,et al.  Phosphorylation of ERK1/2 mitogen‐activated protein kinase is associated with poor response to anti‐hormonal therapy and decreased patient survival in clinical breast cancer , 2001, International journal of cancer.

[58]  Victor G Corces,et al.  Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. , 2004, Trends in genetics : TIG.

[59]  A. Bilancio,et al.  PI3‐kinase in concert with Src promotes the S‐phase entry of oestradiol‐stimulated MCF‐7 cells , 2001, The EMBO journal.

[60]  V. Ogryzko,et al.  Regulation of activity of the transcription factor GATA-1 by acetylation , 1998, Nature.

[61]  B. Katzenellenbogen,et al.  Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. , 1994, The Journal of biological chemistry.

[62]  T. Thorsen,et al.  Phosphorylation of the estradiol receptor in MCF-7 human breast cancer cells in culture , 1990, Molecular and Cellular Endocrinology.

[63]  Simak Ali,et al.  Phosphorylation of Human Estrogen Receptor α by Protein Kinase A Regulates Dimerization , 1999, Molecular and Cellular Biology.

[64]  B. Katzenellenbogen,et al.  Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[65]  W. Bai,et al.  Regulation of Estrogen Receptor Nuclear Export by Ligand-Induced and p38-Mediated Receptor Phosphorylation , 2002, Molecular and Cellular Biology.

[66]  C. Monnig,et al.  Determinants for substrate phosphorylation by p21-activated protein kinase (gamma-PAK). , 1997, Biochemistry.

[67]  D. Lannigan.  Estrogen receptor phosphorylation , 2003, Steroids.